USPTO serial 77316878
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jayme M. Torelli
Jayme M. Torelli Hoffman Warnick LLC75 State Street, 14th FloorAlbany, NY 12207UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and pharmacogenetic applications of those pharmaceuticals, namely, cardiovascular pharmaceuticals, dermatological pharmaceuticals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations for anticoagulants, pharmaceutical preparations for antidepressants, pharmaceutical preparations for appetite suppressants, pharmaceutical preparations for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the inhalation treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for treating wounds, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical preparations for the treatment of bone diseases, pharmaceutical preparations for the treatment of respiratory diseases and asthma, pharmaceuticals, namely, lipid-lowering agents, pharmaceuticals, namely, psychotropics, pharmaceuticals for the treatment of fatigue, and pharmaceuticals for the treatment of autism | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 7, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 24, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 23, 2011 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 21, 2011 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 21, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 22, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Mar 20, 2011 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 14, 2011 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 14, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 28, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 27, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 24, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 24, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 13, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Apr 12, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 12, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 17, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 17, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 8, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 25, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 25, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 26, 2009 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Feb 20, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 10, 2008 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 7, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 7, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 4, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 4, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 27, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 26, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 26, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 26, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 26, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 13, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2008 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 12, 2008 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 11, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2007 | NWAP | NEW APPLICATION ENTERED | — |